(1S,2R)-tranylcypromine has been researched along with N5-(2-chloro-6-phenoxybenzyl)-1H-1,2,4-triazole-3,5-diamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barth, J; Berg, T; Fulda, S; Greve, G; Haas, J; Hau, M; Haydn, T; Jung, M; Kürner, A; Lübbert, M; Lüdeke, S; Robaa, D; Schüle, R; Schulz-Fincke, J; Sippl, W; Willmann, D | 1 |
1 other study(ies) available for (1S,2R)-tranylcypromine and N5-(2-chloro-6-phenoxybenzyl)-1H-1,2,4-triazole-3,5-diamine
| Article | Year |
|---|---|
Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation.
Topics: Animals; Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Enzyme Inhibitors; Histone Demethylases; Humans; Leukemia; Mice; Models, Molecular; Monoamine Oxidase Inhibitors; Structure-Activity Relationship; Tranylcypromine | 2018 |